SOLENO THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.9 USD | +0.51% |
|
+1.80% | +13.79% |
| 13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
| 10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.31% | +1.80% | +13.79% | +965.12% | +56.58% | 1.66B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SLNO Stock
- Charts Soleno Therapeutics, Inc.
- Comparison Chart